Your browser doesn't support javascript.
loading
Real world experience: Examining outcomes using letermovir for CMV prophylaxis in high-risk allogeneic hematopoietic stem cell patients in the setting of using T-cell depletion as GVHD prophylaxis.
Dwabe, Sami; Hsiao, Mindy; Ali, Amir; Rodman, Jack; Savitala-Damerla, Lakshmi; Nazaretyan, Samvel; Kimberly Schiff, N P; Tam, Eric; Ladha, Abdulla; Woan, Karrune; Chaudhary, Preet; Yaghmour, George.
Afiliação
  • Dwabe S; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Hsiao M; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Ali A; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Rodman J; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Savitala-Damerla L; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Nazaretyan S; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Kimberly Schiff NP; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Tam E; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Ladha A; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Woan K; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Chaudhary P; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Yaghmour G; University of Southern California, Keck School of Medicine, LA, Division of Hematology, Norris Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: george.yaghmour@med.usc.edu.
Transpl Immunol ; 76: 101769, 2023 02.
Article em En | MEDLINE | ID: mdl-36464218
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article